0001415889-22-000507.txt : 20220112 0001415889-22-000507.hdr.sgml : 20220112 20220112172147 ACCESSION NUMBER: 0001415889-22-000507 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220111 FILED AS OF DATE: 20220112 DATE AS OF CHANGE: 20220112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOTSON JERROLD DUANE CENTRAL INDEX KEY: 0001388853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 22527266 MAIL ADDRESS: STREET 1: 5 CENTERPOINTE DRIVE STREET 2: SUITE 400 CITY: LAKE OSWEGO STATE: OR ZIP: 97035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-577-3600 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 4 1 form4-01122022_020137.xml X0306 4 2022-01-11 0001411685 VistaGen Therapeutics, Inc. VTGN 0001388853 DOTSON JERROLD DUANE C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false VP, CFO AND SECRETARY Common Stock 2022-01-11 4 M 0 18750 1 A 94571 D Stock Option (Right to Buy) 1 2022-01-11 4 M 0 18750 0 D 2029-05-23 Common Stock 34375 15625 D 25% of the shares subject to this stock option vested May 23, 2019, with the the remaining shares vesting in 1/36th installments on each monthly anniversary thereafter. /s/ Jerrold D. Dotson 2022-01-12